Mmj international holdings

When the Drug Enforcement Administration convenes its marijuana rescheduling hearing on June 29, the most consequential voices in the room may not belong to industry advocates or policy reformers. A

A pharmaceutical cannabinoid company that spent years building a federally compliant operation - DEA-registered labs, FDA Investigational New Drug applications, Orphan Drug Designation - is now in